Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Of mice and men: The factor H protein family and complement regulation.

Pouw RB, Vredevoogd DW, Kuijpers TW, Wouters D.

Mol Immunol. 2015 Mar 27. pii: S0161-5890(15)00115-7. doi: 10.1016/j.molimm.2015.03.011. [Epub ahead of print] Review.

PMID:
25824240
2.

Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.

Mevorach D.

Mol Immunol. 2015 Mar 25. pii: S0161-5890(15)00103-0. doi: 10.1016/j.molimm.2015.03.005. [Epub ahead of print] Review.

PMID:
25818314
3.

Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking.

Ratajczak MZ, Adamiak M.

Leukemia. 2015 Mar 9. doi: 10.1038/leu.2015.66. [Epub ahead of print] Review.

PMID:
25748684
4.

Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Berentsen S, Sundic T.

Biomed Res Int. 2015;2015:363278. doi: 10.1155/2015/363278. Epub 2015 Jan 29. Review.

5.

Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature.

Meppiel E, Crassard I, Peffault de Latour R, de Guibert S, Terriou L, Chabriat H, Socié G, Bousser MG.

Medicine (Baltimore). 2015 Jan;94(1):e362. doi: 10.1097/MD.0000000000000362. Review.

PMID:
25569655
6.

Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.

Wong EK, Kavanagh D.

Transl Res. 2015 Feb;165(2):306-20. doi: 10.1016/j.trsl.2014.10.010. Epub 2014 Oct 20. Review.

PMID:
25468487
7.

[Aplastic anemia].

Schrezenmeier H, Körper S, Höchsmann B.

Dtsch Med Wochenschr. 2014 Dec;139(49):2503-6. doi: 10.1055/s-0034-1387407. Epub 2014 Nov 25. Review. German. No abstract available.

PMID:
25423456
8.

Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.

Martí-Carvajal AJ, Anand V, Cardona AF, Solà I.

Cochrane Database Syst Rev. 2014 Oct 30;10:CD010340. doi: 10.1002/14651858.CD010340.pub2. Review.

PMID:
25356860
9.

Biomechanical properties of red blood cells in health and disease towards microfluidics.

Tomaiuolo G.

Biomicrofluidics. 2014 Sep 17;8(5):051501. doi: 10.1063/1.4895755. eCollection 2014 Sep. Review.

PMID:
25332724
10.

New perspectives on the thrombotic complications of haemolysis.

L'Acqua C, Hod E.

Br J Haematol. 2015 Jan;168(2):175-85. doi: 10.1111/bjh.13183. Epub 2014 Oct 13. Review.

PMID:
25307023
11.

Treatment of autoimmune hemolytic anemias.

Zanella A, Barcellini W.

Haematologica. 2014 Oct;99(10):1547-54. doi: 10.3324/haematol.2014.114561. Review.

12.

Paroxysmal nocturnal hemoglobinuria.

Brodsky RA.

Blood. 2014 Oct 30;124(18):2804-11. doi: 10.1182/blood-2014-02-522128. Epub 2014 Sep 18. Review.

PMID:
25237200
13.

Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models.

Vogel CW, Finnegan PW, Fritzinger DC.

Mol Immunol. 2014 Oct;61(2):191-203. doi: 10.1016/j.molimm.2014.06.035. Epub 2014 Jul 22. Review.

PMID:
25062833
14.

Misleading hemoglobin A1c levels in a patient with paroxysmal nocturnal hemoglobinuria.

Xia D, McShine R, Berg AH.

Am J Clin Pathol. 2014 Aug;142(2):261-5. doi: 10.1309/AJCPTK1HPR2KULJU. Review.

PMID:
25015870
15.

Complement the hemostatic system: an intimate relationship.

Weitz IC.

Thromb Res. 2014 May;133 Suppl 2:S117-21. doi: 10.1016/S0049-3848(14)50020-5. Review.

PMID:
24862131
16.

[Anticomplement treatment of PNH in the era of Eculizumab: problems and outlook].

Wu Z, Zhang F.

Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):266-8. doi: 10.3760/cma.j.issn.0253-2727.2014.03.024. Review. Chinese. No abstract available.

17.

Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.

Frietsch JJ, Dornaus S, Neumann T, Scholl S, Schmidt V, Kunert C, Sayer HG, Hochhaus A, La Rosée P.

Eur J Haematol. 2014 Sep;93(3):247-59. doi: 10.1111/ejh.12311. Epub 2014 Apr 9. Review.

PMID:
24635656
18.

Refractory anemia with ring sideroblasts.

Malcovati L, Cazzola M.

Best Pract Res Clin Haematol. 2013 Dec;26(4):377-85. doi: 10.1016/j.beha.2013.09.005. Epub 2013 Oct 1. Review.

PMID:
24507814
19.

[Current therapeutic strategy for hemolytic anemia: paroxysmal nocturnal hemoglobinuria].

Nishimura J.

Rinsho Ketsueki. 2014 Jan;55(1):22-8. Review. Japanese. No abstract available.

PMID:
24492033
20.

Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.

Kastrinaki MC, Pavlaki K, Batsali AK, Kouvidi E, Mavroudi I, Pontikoglou C, Papadaki HA.

Clin Dev Immunol. 2013;2013:265608. doi: 10.1155/2013/265608. Epub 2013 Dec 10. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk